Navigation Links
Small Change Could Stop Epilepsy Seizures for Millions

Medicine costing less than three dollars a year per patient could spare 30 millions poor people, many of them children, from the trauma and torment of epilepsy, a new study released Friday has found .

Some 85 percent of epilepsy sufferers in the developing world go without any treatment whatsoever because they cannot afford the drugs most often prescribed to impede the terrible seizures associated with the illness.

The least expensive of these medications, phenobarbital, has been recommended by the World Health Organization (WHO) for victims of convulsive seizures in poor countries, but has been otherwise shunned because it is thought to have more serious side-effects, especially on children.

A drug trial of 108 children in Bangladesh, however, comparing phenobarbital with carbamazepine -- commonly prescribed for epilepsy -- showed the less expensive drug to be equally effective. The study, led by paediatric neurophysiologist Selina Banu and to be published in the British Medical Journal, also concluded it did not provoke more behavioural problems, such as hyperactivity and restlessness.

A follow-up study a year later confirmed the initial findings. Carbamazepine, sold in generic form, retails for about 700 dollars (520 euros) at adult doses for a year's treatment, compared to less than three dollars for phenobarbital. "The burden of untreated epilepsy in terms of human suffering and social costs is enormous," the British Medical Journal said in an accompanying editorial.

"Governments and non-governmental organizations in developing countries need to ensure that effective treatment is effective for all." Epilepsy victims, especially children, are often stigmatized because of unpredictable and violent seizures that can be highly disruptive in daily life.

In some cases major attacks resulting in status epilepticus -- a condition in which seizures last for more than 30 minutes or follow in rapid succession -- require hospitalization.

The researchers cautioned that the conditions of the drug trial, carried out at the Children's Hospital in Dhaka, Bangladesh, were not ideal.

Some children dropped out of the follow up studies and there was a sex-ratio imbalance for one of the drug groups. But even with these shortcomings, the study showed that most children tolerated phenobarbital well and behaviour even improved in many, they reported.


'"/>




Related medicine news :

1. Smallpox as Biological Weapons?
2. Is Smallpox Threat Real ?
3. Smallpox Vaccine May Help Fight Cervical Cancer
4. Smallpox Would Spread Rapidly
5. Drug Firm Offers to Donate Smallpox Vaccine
6. Small aneurysms best left untouched
7. Small lumps in breast if not treated may cause long-term harm
8. Third generation Small pox vaccine from Cell-culture
9. CT Scans Said to Accurately Detect Small Cancers
10. Brain of Cocaine Addicts Smaller In Size
11. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
Breaking Medicine Technology: